Under construction – not a live service
Sign in
Enrolling by invitationNo phase

The Role of Pain Catastrophizing, Resilience, and Illness Perception in Predicting Fibromyalgia Impact in Patients With Fibromyalgia

Key facts

Where
Bilecik, TürkiyeSee the site

Where in Türkiye

  • Bilecik Seyh Edebali UniversityBilecik, TürkiyeNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Bilecik Seyh Edebali Universitesi
Trial code
NCT07846501
Record updated
29 September 2026
Original description
This study aims to reveal the effects of pain catastrophizing, psychological resilience, and illness perception on the impact level of fibromyalgia in patients with fibromyalgia, to determine the predictive power of these psychosocial variables regarding the impact level of fibromyalgia, and to evaluate their roles in explaining the burden of the disease.Read full original descriptionShow less

This study aims to reveal the effects of pain catastrophizing, psychological resilience, and illness perception on the impact level of fibromyalgia in patients with fibromyalgia, to determine the predictive power of these psychosocial variables regarding the impact level of fibromyalgia, and to evaluate their roles in explaining the burden of the disease.

Inclusion: Patients diagnosed with fibromyalgia,; Aged 18 years or older,; Literate in Turkish,; And without communication difficulties.

Exclusion: Those with a disease causing cognitive impairment who are unable to answer the survey questions,; Those with chronic painful medical conditions other than fibromyalgia (e.g., migraine, diabetic neuropathy, rheumatoid arthritis, etc.),; Those diagnosed with neurocognitive, mental, or emotional disorders,; Patients with multisystemic diseases such as cancer.

ClinicalTrials.gov NCT07846501